Latest News in the pharma Industry

Policy & Regulation

FDA Approves First Therapy for High-Risk Neuroblastoma

FDA Approves First Therapy for High-Risk Neuroblastoma

11 Mar 2015

Read more 
Astellas Receives FDA Approval for Cresemba

Astellas Receives FDA Approval for Cresemba

9 Mar 2015

Read more 
New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2015

New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2015

6 Mar 2015

Read more 
FDA Approves Landmark Drug for Lung Cancer Patients

FDA Approves Landmark Drug for Lung Cancer Patients

5 Mar 2015

Read more 
Actavis Receives Approval from the European Commission for Xydalba

Actavis Receives Approval from the European Commission for Xydalba

3 Mar 2015

Read more 
Actavis Receives FDA Approval for Avycaz

Actavis Receives FDA Approval for Avycaz

2 Mar 2015

Read more 
PhRMA Statement on Court Ruling on Maine Importation Law

PhRMA Statement on Court Ruling on Maine Importation Law

27 Feb 2015

Read more 
Novartis Receives FDA Approval of Farydak, the First HDAC Inhibitor for Patients with Multiple Myeloma

Novartis Receives FDA Approval of Farydak, the First HDAC Inhibitor for Patients with Multiple Myeloma

24 Feb 2015

Read more 
FDA Accepts SNDA for Priority Review of Rapamune (sirolimus) for Treatment of Lymphangioleiomyomatosis (LAM)

FDA Accepts SNDA for Priority Review of Rapamune (sirolimus) for Treatment of Lymphangioleiomyomatosis (LAM)

23 Feb 2015

Read more 
FDA Issues New Draft Documents Related to Compounding of Human Drugs

FDA Issues New Draft Documents Related to Compounding of Human Drugs

17 Feb 2015

Read more 
FDA Approves Anticancer Agent Lenvima as Treatment for Radioactive Iodine-Refractory Dirrerentiated Thyroid Cancer

FDA Approves Anticancer Agent Lenvima as Treatment for Radioactive Iodine-Refractory Dirrerentiated Thyroid Cancer

16 Feb 2015

Read more 
SMC Recommends Bosulif for the Treatment of Chronic Myeloid Leukaemia in Scotland

SMC Recommends Bosulif for the Treatment of Chronic Myeloid Leukaemia in Scotland

11 Feb 2015

Read more